Functional characterization of the human biglycan 5'-flanking DNA and binding of the transcription factor c-Krox

Journal of Bone and Mineral Research

Volumn 12, Issue 12, 1997, Pages 2050-2060

  Heegaard, Anne Marie ^a   Robey, Pamela Gehron ^b   Vogel, Walther ^c   Just, Walter ^c   Widom, Russell L ^d   Schøller, Jørgen ^a   Fisher, Larry W ^b   Young, Marian F ^b  

^a CENTER FOR CLINICAL AND BASIC RESEARCH   (Denmark)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF ULM   (Germany)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIGLYCAN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; DNA FLANKING REGION; FIBROBLAST CULTURE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OSTEOBLAST; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; TRANSCRIPTION REGULATION;

EID: 0030780777     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1997.12.12.2050     Document Type: Article

References (36)

1. Bianco P, Fisher LW, Young MF, Termine DJ, Gehron Robey P 1990 Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. J Histochem Cytochem 38:1549-1563.
2. Young MF, Ibaraki K, Kerr JM, Heegaard A-M 1993 Molecular and cellular biology of the major noncollagenous proteins in bone. In: Noda M (ed.) Cellular and Molecular Biology of Bone. Academic Press, Inc., San Diego, CA, U.S.A., pp. 191-234.
3. Hildebrand A, Romaris M, Rasmussen LM, Heinegård D, Twardzik DR, Border WA, Rouslahti E 1994 Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor β. Biochem J 302:527-534.
4. Schönherr E, Witsch-Prehm P, Harrach B, Robenek H, Rauterberg J, Kresse H 1995 Interaction of biglycan with type I collagen. J Biol Chem 270:2776-2783.
5. Yamaguchi Y, Mann DM, Rouslahti E 1990 Negative Regulation of transforming growth factor-β by the proteoglycan decorin. Nature 346:281-284.
6. Fisher LW, Heegaard A-M, Vetter U, Vogel W, Just W, Termine JD, Young MF 1991 Human biglycan gene putative promoter, intron-exon junctions and chromosomal localization. J Biol Chem. 266:14371-14377.
7. Ungefroren H, Krull NB 1996 Transcriptional regulation of the biglycan gene. J Biol Chem 271:15787-15795.
8. Traupe H, van den Ouweland AMW, van Oost BA, Vogel W, Vetter U, Warren ST, Rocchi M, Darlison MG, Ropers H-H 1992 Fine mapping of the human biglycan (BGN) gene within the Xq28 region employing a hybrid cell panel. Genomics 13:481-483.
9. Geerkens C, Vetter U, Just W, Fedarko NS, Fisher LW, Young MF, Termine JD, Gehron Robey P, Wöhrle D, Vogel W 1995 The X-chromosome human biglycan gene BGN is subject to X inactivation but is transcribed like a X-Y homologous gene. Hum Genet 96:44-52.
10. Rao E, Weiss B, Mertz A, Meder J, Schiebel K, Ogata T, Matsuo N, Rappold GA 1995 Construction of a cosmid contig spanning the short stature candidate region in the pseudoautosomal region PAR 1. In: Albertsson-Wikland K, Ranke M (eds.) Turner Syndrome in a Life-Span Perspective. Elsevier Science B.V., pp. 19-24.
11. Turner HH 1938 A syndrome of infantilism, congenital webbed neck, and cubitus valgus. Endocrinology 23:566-574.
12. Hall JG, Lopez-Rangel E 1995 In: Albertsson-Wikland K, Ranke M (eds.) Turner Syndrome in a Life-Span Perspective. Elsevier Science B.V., pp. 3-9.
13. Galéra P, Musso M, Ducy P, Karsenty G 1994 c-Krox, a transcriptional regulator of type I collagen gene expression, is preferentially expressed in skin. Proc Natl Acad Sci USA 91:9372-9376.
14. Galéra P, Park R-W, Ducy P, Mattéi M-G, Karsenty G 1996 c-Krox binds to several sites in the promoter of both mouse type I collagen genes. J Biol Chem 271:21331-21339.
15. Fisher LW, Termine JD, Young MF 1989 Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. J Biol Chem 264:4571-4576.
16. Dreher KL, Asundi V, Matzura D, Cowan K 1990 Vascular smooth muscle biglycan represents a highly conserved proteoglycan within the arterial wall. Eur J Cell Biol 53:296-304.
17. Baker CC 1990 An improved chloramphenicol acetyltransferase expression vector system for mapping transcriptional and post-translational regulatory elements in animal cells. In: Alitalo KK, Huhtala ML, Knowles J, Vaheri A (eds.) Recombinant Systems in Protein Expression. Elsevier Science Publishers B.V., pp. 75-86.
18. Gehron Robey P, Termine JD 1985 Human bone cells in vitro. Calcif Tissue Int 37:453-460.
19. Kuznetsov S, Gehron Robey P 1996 Species differences in growth requirements for bone marrow stromal fibroblast colony formation in vitro. Calcif Tissue Int 56:265-270.
20. Kingston RE, Chen CA, Okayama H 1992 Transfection of DNA into eukaryotic cells. In: Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (eds.) 1991 Current Protocols in Molecular Biology. John Wiley & Sons, Inc., New York, NY, U.S.A., pp. 9.1.1-9.1.9.
21. Liu JM, Fujii H, Green SW, Komatsu N, Young NS, Shimada T 1991 Indiscrimate activity from the B19 promoter in nonpermissive cells. Virology 182:361-364.
22. Gilman M 1991 Removal of contaminating DNA. In: Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (eds.) 1991 Current Protocols in Molecular Biology, John Wiley & Sons, Inc., New York, NY, U.S.A., pp. 4.1.4-4.1.5.
23. Abmayr SM, Workman JL 1993 Preparation of nuclear and cytoplasmic extracts from mammalian cells. In: Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (eds.) 1991 Current Protocols in Molecular Biology, John Wiley & Sons, Inc., New York, NY, U.S.A., pp. 12.1.1-12.1.9.
24. Widom RL, Culic I, Lee J, Korn KH 1997 Cloning and characterization of hcKrox, a transcriptional regulator of extracellular matrix gene expression. Gene (in press).
25. Ibaraki K, Termine JD, Whitson WS, Young MF 1992 Bone matrix mRNA expression in differentiating fetal bovine osteoblasts. J Bone Miner Res 7:743-754.
26. Gronostajski RM 1987 Site-specific DNA binding of nuclear factor I: Effect of spacer region. Nucleic Acids Res 15: 5545-5559.
27. Lee W, Mitchell P, Tjian R 1987 Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell 49:741-752.
28. Mitchell PJ, Wang C, Tjian R 1987 Positive and negative regulation of transcription in vitro: Enhancer-binding protein AP-2 is inhibited by SV40 T antigen. Cell 50:847-861.
29. Kadonaga JT, Carner KR, Masiarz Tjian R 1987 Isolation of cDNA encoding transcription factor SpI and functional analysis of the DNA binding domain. Cell 51:1079-1090.
30. Johnson PF, Landschulz WH, Graves BJ, McKnight SL 1987 Identification of a rat liver nuclear protein that binds to the enhancer core element of three animal viruses. Genes Dev 1:133-146.
31. Rau W, Just W, Vetter U, Vogel W 1994 A dinucleotide repeat in the mouse biglycan gene (EST) on the X chromosome. Mamm Genome 5:395-396.
32. Wegrowski Y, Pillarisetti J, Danielson KG, Suzuki S, Iozzo RV 1995 The murine biglycan: complete cDNA cloning, genomic organization, promoter function, and expression. Genomics 30:8-17.
33. Levi G, Topilko P, Schneider-Maunoury S, Lasagna M, Mantero S, Cancedda R, Charnay P 1996 Defective bone formation in Krox-20 mutant mice. Development 22:113-120.
34. Ashworth A, Rastan S, Lovell-Badge R, Kay G 1991 X-chromosome inactivation may explain the difference in viability of X0 humans and mice. Nature 351:406-408.
35. Hunzelmann N, Anders S, Sollberg S, Schönherr E, Krieg T 1996 Co-ordinate induction of collagen type I and biglycan expression in keloids. Br J Dermatol 135:394-399.
36. Santra M, Danielson KG, lozzo RV 1994 Structural and functional characterization of the human decorin gene promoter. J Biol Chem 269:579-587.